AOD 9064 (5 mg)

CRUCIAL DISCLAIMER: It is imperative to heed the warning printed directly on the vial label: "FOR RESEARCH USE ONLY. NOT FOR HUMAN USE."

AOD-9064 is classified solely as a research chemical.

Properties Studied in Research:

AOD-9064 (which AOD-9064 appears to be a variation or batch designation of) has primarily been investigated for its potential effects on metabolism.

• Lipolysis (Fat Burning): Most research focus centers on its alleged ability to stimulate the breakdown of fat cells (lipolysis) and potentially inhibit the formation of new fat cells (lipogenesis).

• Hormonal Sparing: Research indicates that this specific fragment aims to achieve fat metabolic changes without the growth-promoting (IGF-1 elevating) or blood sugar effects associated with full human growth hormone.

• Potential Side Effects: Because it is not approved for human consumption, comprehensive clinical safety data is limited. Like other injectable peptides, standard risks could include injection site reactions (pain, swelling, redness), headache, or digestive upset. Long-term risks associated with off-label human use are unknown.

All compounds are supplied as lyophilized (freeze-dried) powder to support stability during storage and shipping. Products are intended for laboratory research purposes only.